Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach
Abstract Cancer therapy is a dynamically evolving field, witnessing the emergence of innovative approaches that offer a promising outlook for patients grappling with persistent disease. Within the realm of therapeutic exploration, chimeric antigen receptor (CAR) T cells as well as CAR NK cells, have...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-09-01
|
Series: | Journal of Extracellular Biology |
Subjects: | |
Online Access: | https://doi.org/10.1002/jex2.70011 |